ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMAS trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on tough esophageal cancer
Disease control OngoingThis study is testing a three-part treatment for people with advanced esophageal cancer who cannot have surgery. First, patients receive immunotherapy plus chemotherapy, followed by a combination of chemotherapy and radiation. The goal is to see if this approach helps control the…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat esophageal cancer?
Disease control OngoingThis study is testing whether a new drug called SI-B001, when combined with an existing chemotherapy drug (irinotecan), can help control advanced esophageal cancer that has come back or spread after initial treatment. It involves 22 adults whose cancer worsened despite prior immu…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMAS
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC